Market Cap | 17.44M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -4.29M | Forward P/E | -29.43 | EPS next Y | - | 50D Avg Chg | 10.00% |
Sales | 36.75k | PEG | - | EPS past 5Y | - | 200D Avg Chg | 20.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -26.00% |
Recommedations | - | Quick Ratio | 0.02 | Shares Outstanding | 10.89M | 52W Low Chg | 845.00% |
Insider Own | 50.42% | ROA | -417.17% | Shares Float | 5.54M | Beta | 0.61 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 2.06 |
Gross Margin | 49.38% | Profit Margin | - | Avg. Volume | 633 | Target Price | - |
Oper. Margin | -33,852.95% | Earnings Date | Aug 13 | Volume | 5 | Change | 0.00% |
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program for substance abuse that includes peer recovery support; and distributes UnCraveRx weight loss management program, a medically assisted weight management program. The company is also developing BICX101, an injectable and implantable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Lucido Louis C. | Director Director | Jan 24 | Buy | 1.20 | 200 | 240 | 101,259 | 01/25/23 |
Lucido Louis C. | Director Director | Jan 13 | Buy | 1.13 | 4,000 | 4,520 | 101,059 | 01/17/23 |
Lucido Louis C. | Director Director | Dec 12 | Buy | 0.84 | 5,000 | 4,200 | 89,425 | 12/15/22 |
Lucido Louis C. | Director Director | Aug 29 | Buy | 2.11 | 3,878 | 8,183 | 80,385 | 08/31/22 |
Lucido Louis C. | Director Director | Aug 25 | Buy | 2.15 | 1,060 | 2,279 | 76,507 | 08/29/22 |